Gina

CE
PR
OD
U
RE
OR
AL
TE
R
NO
T
DO
IG
HT

ED

MA

TE
RI
AL
-

®

CO
P

YR

GLOBAL STRATEGY FOR THE
DIAGNOSIS AND MANAGEMENT OF ASTHMA
IN CHILDREN 5 YEARS AND YOUNGER
Available at www.ginasthma.org

CE
PR
OD
U
RE
OR
AL
TE
R
NO
T
DO
TE
RI
AL
MA
ED
IG
HT
YR
CO
P

Disclaimer: Although the recommendations of this document are based on thebest published evidence, it is the
responsibility of practicing physicians to consider the cost and benefit of all treatments prescribed in young children,
with due reference to recommendations and licensed formulations, dosing, and indications for use in their country.
© Global Initiative for Asthma (GINA)

PR
OD
U

CE

Global Strategy for Asthma Management and Prevention
inChildren 5 Years and Younger

GINA Science Committee

Eric D. Bateman, MD, Chair
Cape Town, South Africa

Mark FitzGerald, MD, Chair
Vancouver, BC, Canada

Louis-Philippe Boulet, MD
Sainte-Foy, Quebec, Canada

Peter J. Barnes, MD
London, England, UK

Alvaro Cruz, MD
Salvador, Brazil

Neil Barnes, MD
London, England, UK

Mark FitzGerald, MD
Vancouver, BC, Canada

Eric D.Bateman, MD
Cape Town, South Africa

Tari Haahtela, MD
Helsinki, Finland

*Allan Becker, MD
Winnipeg, Manitoba, Canada

Mark Levy, MD
London, England, UK

Jeffrey M. Drazen, MD
Boston, MA, USA

OR

AL
TE
R

NO
T

Paul O'Byrne, MD
Ontario, Canada

*Robert F. Lemanske, Jr, MD
Madison, WI, USA

DO

Ken Ohta, MD
Tokyo, Japan

TE
RI
AL
-

Pierluigi Paggiaro, MDPisa, Italy
*Soren Erik Pedersen, MD
Kolding, Denmark

ED

Wan-Cheng Tan, MD
Vancouver, BC, Canada

MA

*Manuel Soto-Quiroz, MD
San José, Costa Rica

YR

IG
HT

*Gary W. Wong, MD
Hong Kong ROC

CO
P

RE

Executive Committee (2008)

Paul O'Byrne, MD
Hamilton, Ontario, Canada
Ken Ohta. MD, PhD
Tokyo, Japan
Soren Erik Pedersen, MD
Kolding, Denmark
Emilio Pizzichini,MD
Florianópolis, Brazil
Helen K. Reddel, MD
NSW, Australia
Sean D. Sullivan, PhD
Seattle, WA, USA
Sally E. Wenzel, M.D.
Pittsburgh, PA, USA
*Heather J. Zar, MD
Cape Town, South Africa

*Participants in Panel to develop the report. Also included was Peter D. Sly MD, Telethon Institute for
Child Health Research, Centre for Child Health Research, University of Western Australia,Perth,
Western Australia, Australia.

i

CE

Reviewers
Jacque de Blic, MD
Paris, France

PR
OD
U

Hugo E. Neffen, MD
Santa Fe, Argentina
Lexley M Pinto Pereira, MBBS, MD
Trinidad, West Indies

Johan De Jongste, MD
Rotterdam, The Netherlands.
Renato Stein, MD
Rio Grande do Sul, Brazil

Young Soo Shim, MD
Seoul, Korea

Stan Szefler, MD
Denver, CO, USA

RE

PetrPohunek, MD
Czech Republic

GINA Assembly Members
Submitting Comments

Chen Yu Zhi, MD
Beijing, P.R.China

AL
TE
R

OR

Göran Wennergren, MD
Göteborg, Sweden

Haluk Turktas, MD
Bulent Karadag, MD
Bulent Sekerel, MD
Hasan Yuksel, MD
Ankara, stanbul, Manisa, Turkey

NO
T

Carlos E. Baena-Cagnani, MD
Cordoba, Argentina
Chunxue Bai, MD, PhD
Shanghai, China

DO

Hisbelloda Silva Campos, MD
Rio De Janeiro, RJ Brazil

TE
RI
AL
-

Motohiro Ebisawa, MD, Ph.D
Kanagawa, Japan
Aziz Koleilat, MD
Beirut, Lebanon

IG
HT

Eva Mantzouranis, MD
Heraklion, Crete, Greece

ED

Sohei Makino, MD
Shigemi Yoshihara, MD
Dokkyo, Japan

MA

Le Thi Tuyet Lan, MD, PhD
Ho Chi Minh City, Viet Nam

ii

CO
P

YR

Yousser Mohammad, MD
Gazal Dib, MDSamira Mohammad, MD
Fatmeh Dmeiraoui, MD
Lattakia, Syria

TABLE OF CONTENTS

Pharmacotherapy........................................................5
Table 3: Choosing an Inhaler Device
for Children with Asthma ........................6
Controller Medications ..............................................7
Comparisons Between Controller Medications .........8
Reliever Medications...